Tonix Pharmaceuticals Holding Corp.
TNXP
$13.22
$1.2410.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.32% | -46.55% | -13.22% | -68.00% | 23.88% |
| Total Depreciation and Amortization | 13.73% | 5.86% | -4.55% | -2.03% | -0.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -67.50% |
| Total Other Non-Cash Items | 72.81% | -47.00% | -61.17% | 86.28% | 712.57% |
| Change in Net Operating Assets | -182.55% | 814.29% | -91.69% | 325.96% | -151.15% |
| Cash from Operations | -6.73% | -37.76% | -94.04% | 10.53% | -13.32% |
| Capital Expenditure | 9.71% | -94.80% | -82.54% | -8,683.33% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | -65.72% | -6.13% | 62.11% | -42,216.67% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -1,268.79% |
| Issuance of Common Stock | -70.15% | -28.51% | 580.39% | -77.70% | -27.65% |
| Repurchase of Common Stock | -- | -- | 100.00% | 4.76% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.47% | -0.23% | -514.58% | 78.55% | 31.13% |
| Cash from Financing | -65.84% | -37.65% | 762.92% | -77.81% | -41.83% |
| Foreign Exchange rate Adjustments | 142.86% | -250.00% | 0.00% | 55.56% | -137.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.94% | -71.65% | 1,120.10% | -119.38% | -53.31% |